Patient Assistance Programs are a lifeline, but the administrative burden to access them is a barrier itself.

Manufacturer patient assistance programs exist because specialty medications are expensive and not everyone can afford them. The intent is straightforward: a pharmaceutical company makes a drug available at no cost or reduced cost to patients who meet income and insurance eligibility criteria. For a patient who cannot afford a $4,000 biologic, a PAP approval can mean the difference between starting treatment and not starting it at all.

The intent is good. The execution is a different story.

The administrative burden required to access a PAP is, in many cases, substantial enough to function as a barrier. Not because patients are unwilling. Not because the programs do not have the funding. But because the process of applying, enrolling, and maintaining enrollment was designed without the patient's capacity in mind. And in most practices, nobody owns the process of getting it done.

What a PAP application actually requires

Every manufacturer runs its own program with its own rules. There is no standard application. There is no shared portal. There is no universal eligibility threshold. What is consistent across programs is the volume of documentation required and the pace at which that documentation expires.

A typical PAP application asks for some combination of the following.

Proof of income. This usually means recent tax returns, Social Security award letters, pay stubs, or a signed attestation for patients with no formal income documentation. For patients who are elderly, homeless, or undocumented, assembling income verification can take days or weeks.

Insurance documentation. The program needs to know what coverage the patient has, what it covers, and in some cases why it is not covering the drug. For Medicare beneficiaries, this often means providing Part A and Part B cards, a Part D plan summary, and sometimes an explanation of benefits showing what the plan paid or denied.

A completed physician signature. The prescribing physician has to sign the application, certify the diagnosis, and in some programs provide a letter of medical necessity. Getting a physician signature is not always fast. It depends on the physician's availability, the practice's internal process for handling PAP paperwork, and whether anyone in the office is tracking the application at all.

Proof of residency. A utility bill or lease agreement for patients with stable housing. For patients in transitional housing or living with family, this becomes a problem.

Once submitted, the application goes to the manufacturer's review team. Approval timelines vary by program. Some programs respond within days. Others take two to four weeks. During that window, the patient typically has no medication and no guaranteed timeline.

And then the enrollment expires.

Most PAP approvals are not permanent. They run for 90 days, six months, or a year, depending on the program. When the enrollment period ends, the entire process starts over. New income documentation. New physician signature. New submission. For a patient managing a chronic condition on a permanent specialty medication, this is not a one-time event. It is a recurring administrative obligation that has to be managed alongside everything else their condition requires.

The PAP process was not designed around the patient who needs it most. It was designed around a compliance requirement. Those are not the same thing.

Who carries the burden

In theory, the burden of a PAP application is shared between the patient and the practice. In practice, it falls on whoever cares enough to follow through.

For patients, the documentation requirements alone are prohibitive for many. An elderly Medicare beneficiary managing multiple conditions may not have easy access to their tax returns. A recently unemployed patient may not have current pay stubs. A patient with limited English proficiency may not be able to read the application at all. The programs that are theoretically available to them require a level of administrative capacity that their life circumstances often do not support.

For practices, PAP management falls into a category of work that is essential to patient outcomes but not directly reimbursed. Prior authorizations, benefit verifications, and PAP applications are all part of the specialty access workflow. They take time. They require specific knowledge of individual manufacturer programs. And they do not generate revenue on their own. A practice that does not have a dedicated access team is a practice that handles PAP applications inconsistently, which means some patients get enrolled and some patients do not, based largely on who happened to be available and paying attention.

The consequences of that inconsistency are not evenly distributed. Patients with more resources, more health literacy, and more capacity to advocate for themselves are more likely to follow up, push for answers, and navigate the process even when the practice does not support them. Patients without those resources are more likely to fall out of the process silently.

The renewal problem

If the initial application is hard, the renewal process is where the system loses patients it already helped.

A patient who was enrolled in a PAP twelve months ago and is managing their condition well on the medication has no obvious reason to think about their enrollment status. The medication is working. The prior authorization is in place. Everything feels stable.

Then the enrollment expires. The manufacturer stops shipping. The pharmacy has no medication to dispense. The patient calls the practice, and nobody knows what happened because nobody was tracking the renewal date.

This is not an edge case. It is one of the most common ways that PAP access breaks down in specialty practices. The initial enrollment gets done, often heroically, by someone who recognized the need and pushed the application through. But the system for tracking renewals, flagging expiration dates, and initiating re-enrollment before the gap happens does not exist in most practices.

The result is a patient who was stable on a medication they could not otherwise afford, who then goes without it for two to four weeks while the practice scrambles to re-enroll them. For conditions like rheumatoid arthritis, MS, or oncology indications, a two-week treatment gap is not trivial.

An enrollment that expires without a renewal is not a minor administrative failure. It is a treatment interruption for a patient who had no reason to expect one.

What the manufacturer side of this looks like

It is worth naming that pharmaceutical manufacturers have an interest in patients accessing their medications. A patient who cannot afford the drug does not generate revenue. PAP programs are partly humanitarian and partly commercial. The programs exist because they make financial sense as well as ethical sense.

But the programs are also compliance structures. They have income eligibility requirements, insurance status requirements, and documentation requirements that exist partly to ensure the manufacturer is not subsidizing patients who could afford the drug or who have insurance coverage that should be paying for it. Those requirements are legitimate. They are also the source of the administrative burden.

What is less defensible is the lack of standardization across programs. Every manufacturer has a different portal, a different application form, a different renewal cycle, and a different set of documentation requirements. A practice managing patients on five different specialty biologics is managing five different PAP systems simultaneously. The cumulative administrative load is significant, and it falls entirely on the practice.

Some manufacturers have made genuine investments in streamlining their programs. Dedicated hub services, digital enrollment portals, and proactive renewal reminders exist in some programs and not others. The gap between the best-run programs and the worst-run programs is large enough to affect patient outcomes.

Where the access failure lives

The PAP application burden is not a patient education problem. Telling patients that PAP programs exist does not help a patient who cannot assemble the documentation, cannot follow up on the application status, and has no one at the practice actively managing the process on their behalf.

It is not a manufacturer problem alone either. The programs have funding. The intent to help is real.

It is an infrastructure problem at the practice level. The practices that consistently get patients enrolled and keep them enrolled have built a workflow that owns the PAP process from screening through renewal. They know which patients are enrolled, when enrollments expire, what documentation is coming due, and who is responsible for initiating re-enrollment before the gap happens.

That infrastructure does not exist in most specialty practices. Not because the people in those practices do not care. Because nobody built it, and nobody was hired to own it, and the revenue cycle system was never designed to track it.

The patients who fall through are not failing to access a benefit they were offered. They are falling through a gap in operational infrastructure that nobody has been accountable for closing.

What it takes to close it

A PAP management workflow that actually works has four components.

Screening at the point of prescribing. Not after the PA is denied. Not when the patient reports they cannot afford the drug. At the time the medication is written, as part of the standard benefit verification process. Income and insurance status should be assessed at the same time as coverage and prior authorization requirements.

A centralized tracking system. Every active PAP enrollment, its expiration date, the documentation requirements for renewal, and the responsible staff member should live in one place that gets reviewed regularly. This does not require sophisticated technology. It requires someone who owns it.

Proactive renewal initiation. Renewals should be initiated at least 60 days before the enrollment expires. That window accounts for the time required to gather documentation, obtain physician signatures, and allow for manufacturer processing.

Patient communication that matches their capacity. For patients who cannot manage the documentation requirements independently, the practice needs to either manage it for them or connect them to a patient advocate or social worker who can. Handing a patient a PAP application and telling them to fill it out is not a solution for a patient who cannot fill it out.

None of this is complicated. All of it requires someone to own it.

Taylor McKinney · The Access Gap · @theaccessgap